A new study published in the Journal of American Medical Association showed that adding levodopa to normal inpatient ...

Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of hematological malignancies, today announced that it has received ...

DuPont will release its fourth quarter and full year 2025 financial results at 6:00 a.m. ET on Tuesday, February 10, 2026. In addition, the company will host a conference call at 8:00 a.m. ET that ...

A 58-year-old woman was admitted to the hospital 3 weeks after lumbar surgery because of diplopia and fever. Left leg pain and a rash had preceded the fever and diplopia. A diagnosis was made.

One of SeaWorld San Diego’s first rescues of 2026 was in La Jolla following reports of a malnourished fur seal pup in the ...

​A “busy person” all his life, 73-year-old Gerard ‘Gerry’ Heaney from Craigavon was diagnosed in 2018 with the rare and ...

There was an almost four-fold increase in the number of people being treated for the addictive use of volatile inhalants such as aerosols and nitrous oxide in a three-year period, an Oireachtas ...

Kinder Surprise Eggs – The Chocolate Treat America Can’t Have Kinder Surprise Eggs – The Chocolate Treat America Can’t Have ...

The INSIDE Institute for NeuroAI has taken the use of non-invasive BCIs out of the lab and into the real world.

CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...

Key points A 75-year-old woman presented to the emergency department with acute confusion and lethargy on the third day of ...